Business · 30/03/1994Updated: 10/15/2026 · 1 min read
Akorn, Inc., et al.; Withdrawal of Approval of 18 Abbreviated Antibiotic Applications
Summary
The Food and Drug Administration (FDA) is withdrawing approval of 18 abbreviated antibiotic applications after receiving written notifications from their holders that the drug products were no longer marketed.
Original source language: Federal Register — Health and Human ServicesOpen original release →